CoChat

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications

Open access
Schröter, David, Höhn, Annika · 2019 · Current Pharmaceutical Design

Abstract

Aging is one of the biggest risk factors for the major prevalent diseases such as cardiovascular diseases, neurodegeneration and cancer, but due to the complex and multifactorial nature of the aging process, the molecular mechanisms underlying age-related diseases are not yet fully understood. Research has been intensive in the last years aiming to characterize the pathophysiology of aging and develop therapies to fight age-related diseases. In this context advanced glycation end products (AGEs) have received attention. AGEs, when accumulated in tissues, significantly increase the level of inflammation in the body which has long been associated with the development of cancer. Here we discuss the classical settings promoting AGE formation, as well as reduction strategies, occurrence and relevance of AGEs in cancer tissues and the role of AGE-interaction with the receptor for advanced glycation end products (RAGE) in cancer initiation and progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1381612825666190130145549

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. (1) Simplified AGE-mediated activation of an inflammatory response leading to cancer onset and/or progession. AGE-RAGE interaction triggers the activation of transcription factors transducing inflammatory signals, mainly NF-κB, leading to an increased cytokine secretion, followed by lymphoid and myeloid immune cells recruitment into the tumor microenvironment, elevated ROS production, and an inflammatory response. NF-κB activation also increases RAGE expression, creating a positive feedback cycle. In addition, reactive intermediates generated during AGE formation can directly increase ROS production promoting the immune response and the formation of further AGEs creating a chronic inflammatory state. Membrane and RAGE receptor illustration were used from Servier Medical Art under creative commons license 3.0 (https://smart.servier.com/).
Fig. (1) Simplified AGE-mediated activation of an inflammatory response leading to cancer onset and/or progession. AGE-RAGE interaction triggers the activation of transcription factors transducing inflammatory signals, mainly NF-κB, leading to an increased cytokine secretion, followed by lymphoid and myeloid immune cells recruitment into the tumor microenvironment, elevated ROS production, and an inflammatory response. NF-κB activation also increases RAGE expression, creating a positive feedback cycle. In addition, reactive intermediates generated during AGE formation can directly increase ROS production promoting the immune response and the formation of further AGEs creating a chronic inflammatory state. Membrane and RAGE receptor illustration were used from Servier Medical Art under creative commons license 3.0 (https://smart.servier.com/).CC BY-NC · PubMed Central
Fig. (2) The paradigm of AGE restriction, inhibition of AGE formation and accumulation.
Fig. (2) The paradigm of AGE restriction, inhibition of AGE formation and accumulation.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 102 references

Research works printed but not linked: 3

  1. Andres R, Pozefsky T, Swerdloff RS, Tobin JD.
  2. Namiki M.
  3. Uribarri J, Woodruff S, Goodman S.

Cited by

See all 138

Metadata

Authors
Schröter, D., & Höhn, A.
Affiliations
German Institute of Human Nutrition (DE)
Corresponding author
Höhn, Annika
Venue
Current Pharmaceutical Design
Published
2019-03-29
Volume
24
Issue
44
Pages
5245-5251
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2913046669
Cited by
126
References
101
Citations by year
2026: 12 · 2025: 12 · 2024: 20 · 2023: 24 · 2022: 21 · 2021: 22 · 2020: 10 · 2019: 5
FWCI
1.89
Type
journal article
Language
en
Open access
Locations
  • Current Pharmaceutical Design (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
German Ministry of Education and Research (82DZD00302)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Potato Plant Research
  • Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
Keywords
advanced glycation end products, carcinogenesis, receptor for advanced glycation end products, RAGE, aging, inflammation, AGE formation, tumor progression, tumor initiation, age-related diseases
MeSH terms
Receptor for Advanced Glycation End Products, Animals, Humans, Inflammation, Neoplasms, Glycation End Products, Advanced, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications. https://app.cochat.ai/papers/10.2174/1381612825666190130145549
The paper
Schröter, D., & Höhn, A. (2019). Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications. Current Pharmaceutical Design. https://doi.org/10.2174/1381612825666190130145549

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.